Multifunctional Hydrogels that Promote Osteogenic Human Mesenchymal Stem Cell Differentiation Through Stimulation and Sequestering of Bone Morphogenic Protein 2


  • This work was supported by the National Institute of Health (DE016523) and the Department of Education's GAANN program and a NSF-GRF (fellowship to D.S.W.B.).


The extracellular environment controls many cellular activities thereby linking external material cues to internal cell function. By better understanding these processes, synthetic extracellular material niches can be tailored to present cells with highly regulated physical and/or chemical cues that promote or suppress selected cell functions. Here, poly(ethylene glycol) (PEG) hydrogels are functionalized with fluvastatin-releasing grafts and growth-factor-binding heparin domains to enable the dynamic exchange of information between the material and cells from the outside-in and inside-out (i.e., bidirectional signaling). By incorporating a fluvastatin-releasing graft and carefully controlling the dose and temporal release, materials are designed to promote bone morphogenic protein 2 (BMP2) and alkaline phosphatase (ALP) production by human mesenchymal stem cells (hMSCs). When the release of fluvastatin is controlled to occur over 2 weeks, BMP2 and ALP production is increased 2.2-fold and 1.7-fold, respectively, at day 28 compared to hMSCs cultured in the absence of fluvastatin. By introducing a heparin functionality into the gel to sequester and localize the hMSC-produced BMP2, the osteogenic differentiation of hMSCs is further augmented over fluvastatin delivery alone. Osteopontin and core-binding factor α1 gene expression is sixfold and fourfold greater, respectively, for hMSCs exposed to fluvastatin in the presence of the heparin functionalities. These results demonstrate how multifunctional gels that interact with cells in a bidirectional manner can efficiently promote selected cell functions, such as the osteogenic differentiation of hMSCs.